Theclinic (SW) Ltd 28/02/2021 iXBRL

THECLINIC (SW) LIMITED - Company Information

28/02/2021 2021-02-28 false false false false false false false false false false true false false true false false false false false false false false No description of principal activities is disclosed 2020-02-29 Sage Accounts Production 21.0 - FRS102_2014 xbrli:pure xbrli:shares iso4217:GBP 11031351 2020-02-29 2021-02-28 11031351 2021-02-28 11031351 2019-02-28 2020-02-28 11031351 2020-02-28 11031351 bus:Director1 2020-02-29 2021-02-28 11031351 core:WithinOneYear 2021-02-28 11031351 core:WithinOneYear 2020-02-28 11031351 core:AfterOneYear 2021-02-28 11031351 core:AfterOneYear 2020-02-28 11031351 core:ShareCapital 2021-02-28 11031351 core:ShareCapital 2020-02-28 11031351 core:RetainedEarningsAccumulatedLosses 2021-02-28 11031351 core:RetainedEarningsAccumulatedLosses 2020-02-28 11031351 core:CostValuation core:Non-currentFinancialInstruments 2021-02-28 11031351 core:Non-currentFinancialInstruments 2021-02-28 11031351 core:Non-currentFinancialInstruments 2020-02-28 11031351 bus:Director1 2020-02-28 11031351 bus:Director1 2021-02-28 11031351 bus:Director1 2019-02-27 11031351 bus:Director1 2020-02-28 11031351 bus:Director1 2019-02-28 2020-02-28 11031351 bus:SmallEntities 2020-02-29 2021-02-28 11031351 bus:AuditExemptWithAccountantsReport 2020-02-29 2021-02-28 11031351 bus:FullAccounts 2020-02-29 2021-02-28 11031351 bus:SmallCompaniesRegimeForAccounts 2020-02-29 2021-02-28 11031351 bus:PrivateLimitedCompanyLtd 2020-02-29 2021-02-28

Company registration number: 11031351

Theclinic (SW) Ltd

Unaudited filleted financial statements

28 February 2021

THECLINIC (SW) LTD

Contents

Statement of financial position

Notes to the financial statements

THECLINIC (SW) LTD

STATEMENT OF FINANCIAL POSITION

28 FEBRUARY 2021

		2021		2020
	Note	£	£	£	£

Fixed assets
Investments	5	230,000		230,000
		_______		_______
			230,000		230,000

Current assets
Cash at bank and in hand		2,997		13,230
		_______		_______
		2,997		13,230
Creditors: amounts falling due
within one year	6	( 136,900)		( 136,698)
		_______		_______
Net current liabilities			( 133,903)		( 123,468)
			_______		_______
Total assets less current liabilities			96,097		106,532

Creditors: amounts falling due
after more than one year	7		( 95,625)		( 106,250)
			_______		_______
Net assets			472		282
			_______		_______

Capital and reserves
Called up share capital			1		1
Profit and loss account	8		471		281
			_______		_______
Shareholder funds			472		282
			_______		_______

For the year ending 28 February 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 29 November 2021 , and are signed on behalf of the board by:

Mr S K Haderlein

Director

Company registration number: 11031351

THECLINIC (SW) LTD

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 28 FEBRUARY 2021

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Stanhope House, 9-10 Fore Street, Holsworthy, Devon, EX22 6DT.

Principal activity

The principal activity of the company is that of human health activities.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Fixed asset investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses. Listed investments are measured at fair value with changes in fair value being recognised in profit or loss.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 1 (2020: 1 ).

5. Investments

	Shares in group undertakings and participating interests	Total
	£	£
Cost
At 29 February 2020 and 28 February 2021	230,000	230,000
	_______	_______
Impairment
At 29 February 2020 and 28 February 2021	-	-
	_______	_______
Carrying amount
At 28 February 2021	230,000	230,000
	_______	_______
At 28 February 2020	230,000	230,000
	_______	_______

6. Creditors: amounts falling due within one year

	2021	2020
	£	£
Bank loans and overdrafts	21,250	21,250
Amounts owed to group undertakings and undertakings in which the company has a participating interest	72,067	63,799
Accruals and deferred income	2,134	3,200
Other creditors	41,449	48,449
	_______	_______
	136,900	136,698
	_______	_______

7. Creditors: amounts falling due after more than one year

	2021	2020
	£	£
Bank loans and overdrafts	95,625	106,250
	_______	_______

8. Reserves

Profit and loss account:This reserve records retained earnings and accumulated losses.

9. Directors advances, credits and guarantees

During the year the director entered into the following advances and credits with the company:


	Loans to / (from) director at 29 February 2020	Loans to / (from) the director	Amounts repaid	Balance at 28 February 2021
	£	£	£	£
Director	( 48,449)	10,000	( 3,000)	( 41,449)
	_______	_______	_______	_______


	Loans to / (from) director at 28 February 2019	Loans to / (from) the director	Amounts repaid	Balance at 28 February 2020
	£	£	£	£
Director	( 74,167)	25,718	-	( 48,449)
	_______	_______	_______	_______

Directors' loans are repayable on demand and subject to interest on overdrawn balances at the official rate.

10. Going concern

The financial statements have been prepared on a going concern basis which assumes that the company will continue in operational existence for the foreseeable future. The validity of this assumption depends on the continued support from the company's directors. If the company were unable to continue in operational existence for the foreseeable future, adjustments would have to be made to reduce the balance sheet value of assets to their recoverable amounts, and to provide for further liabilities that might arise, and to reclassify fixed assets as current assets. The directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.